Epicore Biosystems

Cambridge, MA · Founded 2017 · Privately Held (backing)

Developer of a wearable microfluidic sensor technology designed to improve health and drive athletic performance. Epicore Biosystems is based in Cambridge, MA and was founded in 2017. It was valued at $121 million at its later-stage round in May 2025, the last priced event on record. It has raised $43.1 million across 4 recorded rounds; the latest was a $25.7 million early-stage round in Dec 2024.

PMV mark · valuation
$121.0M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$43.1M
Last round
Early Stage VC
Dec 2024
What is Epicore Biosystems worth?
$121.0MPrivateMarketView mark · Oct 2026

Valued at $121.0M at its later-stage round, May 2025. Nothing has traded since.

Free account
More of Epicore Biosystems with a free account
  • ·The complete investor list: 13 names
  • ·Watch Epicore Biosystems: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Epicore Biosystems funding history

4 rounds
DateRoundRaisedPost-money
Dec 2024Early Stage VC$25.7M▮
Jan 2024Seed Round$1.5M▮
Nov 2021Early Stage VC$9.5M▮
Oct 2018Seed Round$350K▮
Unlock post-money valuations

Membership and data by Private Market View

Epicore Biosystems valuation

Epicore Biosystems was valued at $121 million at its later-stage round in May 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Epicore Biosystems raised?

Epicore Biosystems has raised $43.1 million across 4 recorded rounds since 2018. The largest was a $9.5 million early-stage round in Nov 2021; the most recent was a $25.7 million early-stage round in Dec 2024.

Epicore Biosystems has filed 6 Form Ds with the SEC since 2018, most recently in Apr 2025 ($25.7 million sold to 4 investors).

How Epicore Biosystems's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Epicore Biosystems, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Epicore Biosystems

What is Epicore Biosystems worth?
Epicore Biosystems is valued at $121.0M as of Oct 2026. Valued at $121.0M at its later-stage round, May 2025. Nothing has traded since.
How much has Epicore Biosystems raised?
Epicore Biosystems has raised $43.1M in total funding across 4 recorded rounds.
When did Epicore Biosystems last raise?
Epicore Biosystems last raised in Dec 2024 (Early Stage VC), raising $25.7M.